ARCHIVES

NCI Cooperative Group Clinical Trials Approved

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

March 22, 2002

Triple-Negative Breast Cancer Increases With Number of Births

March 25, 2011

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010